Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol.
F Van de Werf, J Vanhaecke, I K Jang, W Flameng, D Collen, H De Geest
Circulation. 1987;75:830-836Originally published April 1, 1987
F Van de Werf
I K Jang
H De Geest